Zydus Cadila gets USFDA nod to market Doxazosin tablets Ruby Khatun Khatun16 Oct 2017 10:24 AM ISTNew Delhi: Zydus Cadila has received approval from the US health regulator to market Doxazosin tablets, used for the treatment of high blood pressure...
Lumenis launches its first ever M22 OPT technology for dry and itchy eyes caused by eyelid inflammation Ruby Khatun Khatun16 Oct 2017 10:07 AM ISTNew Delhi: With an increasing use of gadgets like mobiles phones, laptops and computers workaholic people are more prone to dry eye syndrome. Studies...
GlaxoSmithKline shingles vaccine gets approval in Canada Ruby Khatun Khatun16 Oct 2017 9:48 AM ISTCanadian health regulators have approved GlaxoSmithKline’s key shingles vaccine, the company said on Friday.Shingrix, the British pharma company’s...
Merck says will not seek approval of cholesterol treatment Ruby Khatun Khatun16 Oct 2017 9:23 AM ISTMerck & Co Inc said on Wednesday it will not seek regulatory approval for its experimental cholesterol drug, anacetrapib, as the clinical profile...
Lupin launches pain relieving tablets in US Ruby Khatun Khatun15 Oct 2017 11:35 AM ISTNew Delhi: Drug firm Lupin said it has launched its pain relieving Hydrocodone Bitartrate and Acetaminophen tablets in the American market.The company...
Apollo Hospitals joins hands with Samsung to fight non-communicable diseases in India Ruby Khatun Khatun15 Oct 2017 10:35 AM ISTChennai: Samsung India, India’s biggest and most trusted consumer electronics and mobile phones brand, and Apollo Hospitals, Asia’s largest and most...
StanPlus raises 1.1 million dollars of seed funding from Kstart Capital, INSEAD Angels Asia Ruby Khatun Khatun15 Oct 2017 10:30 AM ISTHyderabad: StanPlus, the Hyderabad based medical transportation startup announced securing an investment of $1.1 million funding as Seed funding for a...
Hilleman Labs achieves successful outcome of Phase I/II clinical trial of cholera vaccine Ruby Khatun Khatun15 Oct 2017 10:11 AM ISTHilleman Laboratories has announced the successful completion of Phase I/II Clinical Trials of its novel Oral Cholera Vaccine Hillchol. It was...
Sanofi invests 170 million euros in French vaccines facility Ruby Khatun Khatun15 Oct 2017 10:06 AM ISTPARIS: Sanofi will invest 170 million euros ($202 million) to expand its vaccines manufacturing site at Val-de-Reuil in north-western France, in a...
Johnson and Johnson psoriasis drug gets expanded US approval for teens Ruby Khatun Khatun15 Oct 2017 9:47 AM ISTJohnson and Johnson said on Friday it has received an expanded U.S. approval for its blockbuster psoriasis drug Stelara to treat adolescent patients...
Bayer to sell selected crop science biz to BASF for 7 billion dollar Ruby Khatun Khatun15 Oct 2017 9:21 AM ISTNew Delhi: German drug and agrochemicals major Bayer on Friday announced the sale of selected crop science businesses to BASF for USD 7 billion as...
Ardelyxs constipation drug succeeds in late-stage trial Ruby Khatun Khatun15 Oct 2017 9:00 AM ISTArdelyx Inc said a second late-stage trial of its drug for irritable bowel syndrome with constipation (IBS-C) met the main goal of reducing abdominal...
